Application progress of CT new technologies in adrenal tumors

ZHAO Ying; LIU Ai-lian

Journal of China Clinic Medical Imaging ›› 2017, Vol. 28 ›› Issue (11) : 829-832.

ZHAO Ying, LIU Ai-lian

Author information +

History +

Abstract

Adrenal gland is retroperitoneal organ, it is hard to make a clear diagnosis of tumor because of its multiple types and complicated clinical manifestation. Imaging examination has become a useful tool for the diagnosis of adrenal tumors. The development and application of CT new technologies(dual-energy CT and CT perfusion imaging) provide a new method and idea for the diagnosis of adrenal lesions. CT new technologies, which have been applied in adrenal tumors are reviewed in this article.

Key words

Adrenal gland neoplasms / Tomography, X-ray computed

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHAO Ying, LIU Ai-lian. Application progress of CT new technologies in adrenal tumors[J]. Journal of China Clinic Medical Imaging. 2017, 28(11): 829-832

References

[1]单琨，李常颖. 超声和CT检查对肾上腺区占位性病变的诊断价值对比分析[J]. 天津医科大学学报，2014，20（4）：306-308. [2]曲倩倩，刘庆伟. 3.0T磁共振扩散加权成像对肾上腺肿瘤的鉴别诊断价值[D]. 济南：山东大学医学院，2015：1-40. [3]Altinmakas E, Hobbs BP, Ye H, et al. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard[J]. Abdom Radiol(NY), 2017, 42(2): 577-584. [4]Mann GN, Link JM, Pham P, et al. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma[J]. Ann Surg Oncol, 2006, 13(2): 187-197. [5]盖立平，刘爱连，孙美玉，等. 能谱CT成像多个测量参数分析[J]. 中国医学物理学杂志，2015，32（3）：317-321. [6]Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature[J]. AJR, 1998, 171(1): 201-204． [7]刘永强，万春. CT值在肾上腺腺瘤诊断中的应用价值及其阈值选择[J]. 放射学实践，2009，24（10）：1114-1116. [8]Korobkin M, Brodeur F, Francis IR, et al. CT time-attenuation washout curves of adrenal adenomas and nonadenomas[J]. AJR, 1998, 170(3): 747-752． [9]Wang X, Li K, Sun H, et al. Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography[J]. Oncol Targets and Ther, 2016, 9: 6809-6817. [10]Northcutt BG, Raman SP, Long C, et al. MDCT of adrenal masses: can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?[J]. AJR, 2013, 201(4): 834-839. [11]张龙江，卢光明. 双能量CT：回顾和展望[J]. 放射学实践，2014，29（9）：1016-1020. [12]Boll DT, Patil NA, Paulson EK, et al. Focal cystic high-attenuation lesions: characterization in renal phantom by using photon-counting spectral CT-improved differentiation of lesion composition[J]. Radiology, 2010, 254(1): 270-276. [13]张晓鹏. 探索的精神与乐趣-CT能谱成像临床应用研究中的思考[J]. 中华放射学杂志，2011，45（8）：709-712． [14]刘婧，王鹤，王霄英，等. 双能CT成像鉴别肾上腺良恶性病变的初步研究[J]. 放射学实践，2012，27（3）：242-245． [15]王亚宁，时高峰，杜煜，等. 双源CT对肾上腺少脂肪型腺瘤和转移瘤的鉴别诊断价值[J]. 中国全科学，2015，18（1）：1311-1313. [16]Ju Y, Liu A, Dong Y, et al. The value of nonenhanced single-source dual-energy CT for differentiating metastases from adenoma in adrenal glands[J]. Acad Radiol, 2015, 22(7): 834-839. [17]Shi JW, Dai HZ, Shen L, et al. Dual-energy CT: clinical application in differentiating an adrenal adenoma from metastasis[J]. Acta Radiol, 2014, 55(4): 505-512. [18]Gupta RT, Ho LM, Marin D, et al. Dual-energy CT for characterization of adrenal nodules: initial experience[J]. AJR, 2010, 194(6): 1479-1483. [19]刘静红，刘爱连，田士峰，等. 能谱CT碘含量定量分析乏脂性肾血管平滑肌脂肪瘤与透明细胞癌[J]. 中国医学影像技术，2013，29（11）：1878-1881. [20]鞠烨，刘爱连，汪禾青，等. 单源双能量CT平扫对肾上腺乏脂性腺瘤与转移瘤的鉴别价值[J]. 中华肿瘤杂志，2016，38（11）：826-832. [21]吴春茂，余永强，刘斌，等. CT能谱成像在鉴别肾上腺皮质腺瘤与肺腺癌肾上腺小转移瘤中的价值[J]. 安徽医科大学学报，2013，48（2）：156-159. [22]杨世彤，郭华. 双源CT双能扫描模式在肾上腺腺瘤诊断中的应用价值[D]. 河南：郑州大学附属第一医院，2015：1-64. [23]Mileto A, Nelson RC, Marin D, et al. Dual-energy multidetector CT for the characterization of incidental adrenal nodules: diagnostic performance of contrast-enhanced material density analysis[J]. Radiology, 2015, 274(2): 445-454. [24]Mileto A, Mazziotti S, Gaeta M, et al. Pancreatic dual-source dual-energy CT: is it time to discard unenhanced imaging[J]. Clin Radiol, 2012, 67(4): 334-339. [25]田士峰，刘爱连. 双能CT虚拟平扫进展及临床应用[J]. 国际医学放射学杂志，2014，37（1）：54-57. [26]Slebocki K, Kraus B, Chang DH, et al. Incidental findings in abdominal dual-energy computed tomography: correlation between true noncontrast and virtual noncontrast images considering renal and liver cysts and adrenal masses[J]. J Comput Assist Tomogr, 2017, 41(2): 294-297. [27]Gnannt R, Fischer M, Goetti R, et al. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations[J]. AJR, 2012, 198(1): 138-144． [28]Helck A, Hummel N, Meinel FG, et al. Can single-phase dual-energy CT reliably identify adrenal adenomas?[J]. Eur Radiol, 2014, 24(7): 1636-1642. [29]Kim YK, Park BK, Kim CK, et al. Adenoma characterization: adrenal protocol with dual-energy CT[J]. Radiology, 2013, 267(1): 155-163. [30]Wortman JR, Bunch PM, Fulwadhva UP, et al. Dual-energy CT of incidental findings in the abdomen: can we reduce the need for follow-up imaging?[J]. AJR, 2016, 207(4): W58-W68. [31]Kambadakone A, Yoon SS, Kim TM, et al. CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparision with tumor morphology, circulating and tumor biomarkers, and gene expression[J]. AIR, 2015, 204(1): W11-W18. [32]Qin HY, Sun HR, Wang XF, et al. Correlation between CT perfusion parameters and microvessel density and vascular endothelial growth factor in adrenal tumors[J]. PLoS One, 2013, 8(11): e79911. [33]Qin HY, Sun HR, Li YJ, et al. Application of CT perfusion imaging to the histological differentiation of adrenal gland tumors[J]. Eur J Radiol, 2012, 81(3): 502-507. [34]赵勤余，韩志江，缪飞. 良恶性肾上腺嗜铬细胞瘤的CT诊断及鉴别诊断[J]. 医学影像学杂志，2013，23（5）：746-750. [35]乔中伟，缪飞，朱延波，等. 肾上腺多层CT灌注成像的临床应用研究[J]. 中国医学计算机成像杂志，2008，14（5）：420-424. [36]Qiao ZW, Xia CM, Zhu YB, et al. First-pass perfusion computed tomography: initial experience in differentiating adrenal adenoma from metastasis[J]. Eur J Radiol, 2010, 73(3): 657-663. [37]李雨奇，刘挨师，王杰，等. 容积穿梭CT灌注成像在肾上腺肿瘤诊断的初步研究[J]. 实用放射学杂志，2015，31（2）：272-276.